Here is an item from the Wall Street Journal about another researcher at a major university who did not disclosure significant payments from a pharma company:
Karen Wagner, a child psychiatrist at the University of Texas Medical Branch, is the latest academic psychiatrist to be criticized by Sen. Chuck Grassley (R-Iowa) for failing to fully disclose drug industry ties.
Grassley said in a letter that Wagner didn't disclose more than $150,000 in consulting and speaking fees she received from GlaxoSmithKline in recent years, the WSJ reports. Wagner worked on an NIH study of the treatment of teenage depression that included Glaxo's antidepressant Paxil. Wagner didn't respond to the WSJ's requests for comment. The university said it would look into the alleged discrepancies.
CLICK LINK FOR MUCH MORE
http://blogs.wsj.com/health/2008/09/11/sen-grassley-blasts-psychiatrist-for-failure-to-disclose-industry-funding/
http://snipurl.com/3pde2
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment